Merck (MRK) and Ridgeback Biotherapeutics announced today that their COVID-19 pill — the first oral antiviral of its kind — cut the risk of hospitalizations or deaths by half, and that they would ...

The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...

NEW YORK (WABC) -- Britain has granted a conditional authorization to Merck's coronavirus antiviral, the first pill shown to successfully treat COVID-19. It is the first country to OK the treatment, ...

The FDA's Antimicrobial Drugs Advisory Committee voted 13-10 to recommend that the FDA authorize Merck's antiviral pill to treat COVID-19. Safety concerns include a recommendation that the drug not be ...

When it comes to the fight against COVID-19, there’s a new drug that is showing promising results in fighting the illness. It’s an antiviral pill recently announced by pharmaceutical company Merck.

An antiviral pill has shown to be effective in treating COVID-19, according to Phase 2 trial results released late last week. Should those promising results continue in large-scale Phase 3 trials, the ...

The Biden administration on Thursday announced it would invest more than $3 billion from the American Rescue Plan to accelerate the discovery, development and manufacturing of COVID-19 antiviral ...

(Reuters) – The European Medicine Agency’s review to approve Merck’s antiviral pill molnupiravir, developed with Ridgeback Therapeutics, is set to conclude by the end of the year, the regulator’s head ...

Merck (MRK) announced on Wednesday that its single-tablet antiviral regimen, doravirine and islatravir for adults with HIV, was found to be non-inferior to Gilead’s (GILD) once-daily HIV pill Biktarvy ...

Merck plans to acquire Cidara Therapeutics Inc. in a deal worth $9.2 billion. As part of a deal announced Nov. 14, the Rahway-based drugmaker will gain access to the San Diego-headquartered biotech’s ...